About Ginkgo Bioworks Holdings, Inc. Statistics The DNA stock price is closed at $ 8.09 with a total market cap valuation of $ 469.49M (58.03M shares outstanding). The DNA is trading on NYSE with the sign DNA. DNA price is up -1.94% in the past 24 hours. The DNA stock price ...
Market Cap $606.73M Volume 2,031,038 Prev. Close $11.43 DNA Analysis Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' PathStephen AyersThu, Jan. 30 Ginkgo Bioworks: Unproven Transition But 2025 Is Looking BetterRichard DurantMon, Nov. 18, 20241 Comment Ginkgo Bioworks...
Get Ginkgo Bioworks (DNA:NYSE) real-time stock quotes, news, price and financial information from CNBC.
US Stock MarketDetailed Quotes DNA Ginkgo Bioworks Watchlist 7.340 -0.510-6.50% Close Apr 21 16:00 ET 7.210 -0.130-1.77% Post 20:01 ET 425.97MMarket Cap-0.70P/E (TTM) OverviewOptionsFinancialsAnalysisCompanyNewsCommentsFull Hours 5D Daily Weekly Monthly 1Q 1Y Target Price Forecast ...
According to our live Forecast System, Ginkgo Bioworks Holdings stock is an outstanding long-term (1-year) investment*. "DNA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A
Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know Feb 12, 2025•Zacks Stocks Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength? Feb 6, 2025•Zacks Stocks ...
ginkgo.bio Founded Year 2009 Stage PIPE| IPO Total Raised $796.25M Market Cap 0.46B Stock Price 7.84 Revenue $0000 About Ginkgo Bioworks Ginkgo Bioworks is a biotechnology company that specializes in cell programming and offers a range of services across various sectors. The company provides rese...
Data as of Apr 13, 2025 COMP Nasdaq Composite Index 16,724.46 +337.15 +2.06% NDX Nasdaq-100 18,690.06 +346.49 +1.89% NQUS500LC Nasdaq Us 500 Large Cap 2,793.32 +49.67 +1.81% TradeTalks Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and...
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to p...+ VIEW MORE Sep 30, 2024 Latest Report Feb 28, 2025 Next Earnings 10-K / 10-Q / 8-K Filings Holds more cash than debt on its bal...
Ginkgo Bioworks Holdings Risk Factors New Risk (0) Risk Changed (0) Risk Removed (0) No changes from previous report The chart shows the number of risks a company has disclosed. You can compare this to the sector average or S&P 500 average. The quarters shown in the chart are according...